Login / Signup

Permethrin as a Potential Furin Inhibitor through a Novel Non-Competitive Allosteric Inhibition.

Dongyan FengLe RenJiaqi WuLingling GuoZhitao HanJingjing YangWei XieYanbing WangFanxing XuXin SuDa-Hong LiHao Cao
Published in: Molecules (Basel, Switzerland) (2023)
Furin is a potential target protein associated with numerous diseases; especially closely related to tumors and multiple viral infections including SARS-CoV-2. Most of the existing efficient furin inhibitors adopt a substrate analogous structure, and other types of small molecule inhibitors need to be discovered urgently. In this study, a high-throughput screening combining virtual and physical screening of natural product libraries was performed, coupled with experimental validation and preliminary mechanistic assays at the molecular level, cellular level, and molecular simulation. A novel furin inhibitor, permethrin, which is a derivative from pyrethrin I generated by Pyrethrum cinerariifolium Trev. was identified, and this study confirmed that it binds to a novel allosteric pocket of furin through non-competitive inhibition. It exhibits a very favorable protease-selective inhibition and good cellular activity and specificity. In summary, permethrin shows a new parent nucleus with a new mode of inhibition. It could be used as a highly promising lead compound against furin for targeting related tumors and various resistant viral infections, including SARS-CoV-2.
Keyphrases
  • sars cov
  • small molecule
  • respiratory syndrome coronavirus
  • protein protein
  • physical activity
  • mental health
  • high throughput
  • drug delivery
  • single molecule
  • human health
  • cancer therapy
  • single cell